495 related articles for article (PubMed ID: 34462326)
21. Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal Microenvironment.
Wang HQ; Mulford IJ; Sharp F; Liang J; Kurtulus S; Trabucco G; Quinn DS; Longmire TA; Patel N; Patil R; Shirley MD; Chen Y; Wang H; Ruddy DA; Fabre C; Williams JA; Hammerman PS; Mataraza J; Platzer B; Halilovic E
Cancer Res; 2021 Jun; 81(11):3079-3091. PubMed ID: 33504557
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy with 4-1BBL-Expressing iPS Cell-Derived Myeloid Lines Amplifies Antigen-Specific T Cell Infiltration in Advanced Melanoma.
Kuriyama H; Fukushima S; Kimura T; Kanemaru H; Miyashita A; Okada E; Kubo Y; Nakahara S; Tokuzumi A; Nishimura Y; Kajihara I; Makino K; Aoi J; Masuguchi S; Tsukamoto H; Inozume T; Zhang R; Nakatsura T; Uemura Y; Senju S; Ihn H
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669419
[TBL] [Abstract][Full Text] [Related]
23. SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA.
Wu R; Wang C; Li Z; Xiao J; Li C; Wang X; Kong P; Cao J; Huang F; Li Z; Huang Y; Chen Y; Li X; Yang D; Zhang H; Mai J; Feng G; Deng R; Zhu X
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33158915
[TBL] [Abstract][Full Text] [Related]
24. Oral immunization induces a novel CXCR6
Li JB; Li JJ; Li M; Gao C; Zhang L; Li M; Zhu Q
Scand J Immunol; 2021 Mar; 93(3):e12996. PubMed ID: 33205443
[TBL] [Abstract][Full Text] [Related]
25. Blockade of programmed death ligand 1 enhances the therapeutic efficacy of combination immunotherapy against melanoma.
Pilon-Thomas S; Mackay A; Vohra N; Mulé JJ
J Immunol; 2010 Apr; 184(7):3442-9. PubMed ID: 20194714
[TBL] [Abstract][Full Text] [Related]
26. Induction of Progenitor Exhausted Tissue-Resident Memory CD8
León-Letelier RA; Castro-Medina DI; Badillo-Godinez O; Tepale-Segura A; Huanosta-Murillo E; Aguilar-Flores C; De León-Rodríguez SG; Mantilla A; Fuentes-Pananá EM; López-Macías C; Bonifaz LC
Front Immunol; 2020; 11():583382. PubMed ID: 33240271
[TBL] [Abstract][Full Text] [Related]
27. Tumor perfusion enhancement by ultrasound stimulated microbubbles potentiates PD-L1 blockade of MC38 colon cancer in mice.
Li N; Tang J; Yang J; Zhu B; Wang X; Luo Y; Yang H; Jang F; Zou J; Liu Z; Wang Z
Cancer Lett; 2021 Feb; 498():121-129. PubMed ID: 33129956
[TBL] [Abstract][Full Text] [Related]
28. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
29. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
[TBL] [Abstract][Full Text] [Related]
30.
Zhou S; Zhang S; Zheng K; Li Z; Hu E; Mu Y; Mai J; Zhao A; Zhao Z; Li F
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38302417
[TBL] [Abstract][Full Text] [Related]
31. CX3CR1-CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment.
Yamauchi T; Hoki T; Oba T; Saito H; Attwood K; Sabel MS; Chang AE; Odunsi K; Ito F
JCI Insight; 2020 Apr; 5(8):. PubMed ID: 32255766
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of SHP-1 Expands the Repertoire of Antitumor T Cells Available to Respond to Immune Checkpoint Blockade.
Snook JP; Soedel AJ; Ekiz HA; O'Connell RM; Williams MA
Cancer Immunol Res; 2020 Apr; 8(4):506-517. PubMed ID: 32075800
[TBL] [Abstract][Full Text] [Related]
33. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
[TBL] [Abstract][Full Text] [Related]
34. Auto-aggressive CXCR6
Dudek M; Pfister D; Donakonda S; Filpe P; Schneider A; Laschinger M; Hartmann D; Hüser N; Meiser P; Bayerl F; Inverso D; Wigger J; Sebode M; Öllinger R; Rad R; Hegenbarth S; Anton M; Guillot A; Bowman A; Heide D; Müller F; Ramadori P; Leone V; Garcia-Caceres C; Gruber T; Seifert G; Kabat AM; Mallm JP; Reider S; Effenberger M; Roth S; Billeter AT; Müller-Stich B; Pearce EJ; Koch-Nolte F; Käser R; Tilg H; Thimme R; Boettler T; Tacke F; Dufour JF; Haller D; Murray PJ; Heeren R; Zehn D; Böttcher JP; Heikenwälder M; Knolle PA
Nature; 2021 Apr; 592(7854):444-449. PubMed ID: 33762736
[TBL] [Abstract][Full Text] [Related]
35. The function of the chemokine receptor CXCR6 in the T cell response of mice against Listeria monocytogenes.
Heesch K; Raczkowski F; Schumacher V; Hünemörder S; Panzer U; Mittrücker HW
PLoS One; 2014; 9(5):e97701. PubMed ID: 24832098
[TBL] [Abstract][Full Text] [Related]
36. Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells.
Matsumura S; Wang B; Kawashima N; Braunstein S; Badura M; Cameron TO; Babb JS; Schneider RJ; Formenti SC; Dustin ML; Demaria S
J Immunol; 2008 Sep; 181(5):3099-107. PubMed ID: 18713980
[TBL] [Abstract][Full Text] [Related]
37. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
[TBL] [Abstract][Full Text] [Related]
38. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor beta signaling in CD8
Yuan B; Clark CA; Wu B; Yang J; Drerup JM; Li T; Jin VX; Hu Y; Curiel TJ; Li R
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462142
[TBL] [Abstract][Full Text] [Related]
40. A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity.
Yu X; Guo C; Yi H; Qian J; Fisher PB; Subjeck JR; Wang XY
Cancer Res; 2013 Apr; 73(7):2093-103. PubMed ID: 23333935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
